This small biotech stock is on fire! Aurinia Pharmaceuticals just reported a 46% revenue jump and there’s no sign of slowing down! 📈
Aurinia Pharmaceuticals (AUPH) has recently gained attention in the market due to a series of positive developments. The company’s financial performance in Q1 2024 showed remarkable growth, with total net revenue increasing by 46% year-over-year to $50.3 million.
This article This small biotech stock is on fire! Aurinia Pharmaceuticals just reported a 46% revenue jump and there’s no sign of slowing down! 📈 appeared first on Guerilla Stock Trading.
